Biosimilars Market Scope And Analysis

  • Report Code : TIPHE100001246
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 223
Buy Now

Biosimilars Market Report - Analysis by 2031

Buy Now

Biosimilars Market Report Biosimilars Market Size and Share Biosimilars Market Scope and Analysis

Biosimilars Market Report Scope

Report Attribute Details
Market size in 2021 US$ 18.44 Billion
Market Size by 2028 US$ 136.07 Billion
Global CAGR (2021 - 2028) 34.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Disease Indication
  • Cancer
  • Diabetes
  • Autoimmune Diseases
  • Other Disease Indications
By Drug Class
  • Granulocyte Colony-Stimulating Factor
  • Insulin
  • TNK Blockers & Monoclonal Antibodies
By Route of Administration
  • Intravenous
  • Subcutaneous
By End User
  • Hospital
  • Specialty Clinics
  • Homecare
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Biocon Ltd
  • Sanofi Aventis
  • Celltrion Inc
  • Amgen Inc
  • Pfizer Inc
  • Samsung Bioepis
  • Sanofi SA
  • Coherus BioSciences Inc
  • Dr Reddy
    		•